James Edwards-Smallbone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James Edwards-Smallbone has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Naveed Ahmed Khan
Microbiota Research Center, Istinye University, Istanbul, Turkey
2 shared publications - Robin J. Flynn
Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
2 shared publications - Adrian M. Whatmore
Animal and Plant Health Agency (APHA), Addlestone, Surrey, United Kingdom
1 shared publication Alexandre P. Mylnikov
Institute for Biology of Inland Waters, Russian Academy of Sciences, Yaroslavskaya Oblast, Borok 152742, Russia
1 shared publicationAlexis T. Howe
1 shared publicationAmanda C. King
Department of Statutory and Exotic Bacteria, Veterinary Laboratories Agency, Woodham Lane, New Haw KT15 3NB, United Kingdom
1 shared publication
Latest Publications
- 1 November 2012
- Published by Elsevier in Experimental Parasitology
- Vol. 132 (3) , 367-372
Acanthamoeba interactions with the blood–brain barrier under dynamic fluid flow
- 1 November 2012
- Published by Elsevier in Experimental Parasitology
- Vol. 132 (3) , 367-372
Acanthamoeba interactions with the blood–brain barrier under dynamic fluid flow
- Open Access
- 1 March 2012
- Published by Taylor & Francis in Virulence
- Vol. 3 (2) , 159-163
Next generation of non-mammalian blood-brain barrier models to study parasitic infections of the central nervous system
Transmigration of neuropathogens across the blood-brain barrier is a key step in the development of central nervous system infections, making it a prime target for drug development. The ability of neuropathogens to traverse the blood-brain barrier continues to inspire researchers to understand the specific strategies and molecular mechanisms that allow them to enter the brain. The availability of models of the blood-brain barrier that closely mimic the situation in vivo offers unprecedented opportunities for the development of novel therapeutics.
- 1 March 2012
- Published by Taylor & Francis in Virulence
- Vol. 3 (2) , 159-163
Open AccessNext generation of non-mammalian blood-brain barrier models to study parasitic infections of the central nervous system
Transmigration of neuropathogens across the blood-brain barrier is a key step in the development of central nervous system infections, making it a prime target for drug development. The ability of neuropathogens to traverse the blood-brain barrier continues to inspire researchers to understand the specific strategies and molecular mechanisms that allow them to enter the brain. The availability of models of the blood-brain barrier that closely mimic the situation in vivo offers unprecedented opportunities for the development of novel therapeutics.
- 28 October 2009
- Published by Elsevier in Veterinary Microbiology
- Vol. 142 (3-4) , 450-454
Comparative performance of SNP typing and ‘Bruce-ladder’ in the discrimination of Brucella suis and Brucella canis
- 28 October 2009
- Published by Elsevier in Veterinary Microbiology
- Vol. 142 (3-4) , 450-454
Comparative performance of SNP typing and ‘Bruce-ladder’ in the discrimination of Brucella suis and Brucella canis